CRC
DTIL icon

Curi RMB Capital’s Precision BioSciences DTIL Stock Holding History

Curi RMB Capital’s Portfolio DTIL Stock Details DTIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-11,333
Closed -$154K – 539
2024
Q1 		$154K Buy
+11,333
New +$139K ﹤0.01% 556

Other funds holding DTIL

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Curi RMB Capital's DTIL Position: Q2 2024 in Review

Curi RMB Capital sold out of Precision BioSciences (DTIL) in Q2 2024, closing a stake of 11,333 shares — an estimated $154K sold.

Curi RMB Capital first reported a position in DTIL in Q1 2024 and held it in 1 quarter. The position peaked at $154K in Q1 2024. 47 funds tracked by Wall St. Rank hold DTIL as of Q2 2024.

  • Curi RMB Capital reported no remaining Precision BioSciences position as of Q2 2024 after selling out during the quarter.
  • Curi RMB Capital sold 11,333 Precision BioSciences shares in Q2 2024, an estimated $154K.
  • Curi RMB Capital first reported a position in Precision BioSciences in Q1 2024 and held it in 1 quarter.
  • Curi RMB Capital's Precision BioSciences position peaked at $154K in Q1 2024.
  • 47 funds tracked by Wall St. Rank held Precision BioSciences as of Q2 2024.

Based on Curi RMB Capital's 13F filing for Q2 2024, filed 13 Aug 2024.